Inflammatory priming of human mesenchymal stem cells induces osteogenic differentiation via the early response gene IER3
Open Access
- 7 October 2024
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 38 (19) , e70076
Abstract
Mesenchymal stem cells (MSCs) have gained tremendous interest due to their overall potent pro‐regenerative and immunomodulatory properties. In recent years, various in vitro and preclinical studies have investigated different priming (“licensing”) approaches to enhance MSC functions for specific therapeutic purposes. In this study, we primed bone marrow‐derived human MSCs (hMSCs) with an inflammation cocktail designed to mimic the elevated levels of inflammatory mediators found in serum of patients with severe injuries, such as bone fractures. We observed a significantly enhanced osteogenic differentiation potential of primed hMSCs compared to untreated controls. By RNA‐sequencing analysis, we identified the immediate early response 3 ( IER3 ) gene as one of the top‐regulated genes upon inflammatory priming. Small interfering RNA knockdown experiments established IER3 as a novel positive regulator of osteogenic differentiation. Mechanistic analysis further revealed that IER3 deletion significantly downregulated bone marrow stromal cell antigen 2 (BST2) expression and extracellular signal‐related kinase 1/2 (ERK1/2) phosphorylation in hMSCs, suggesting that IER3 regulates osteogenic differentiation through BST2 and ERK1/2 signaling pathway activation. On the basis of these findings, we propose IER3 as a novel therapeutic target to promote hMSC osteoblastogenesis, which might be of high clinical relevance, for example, in patients with osteoporosis or compromised fracture healing.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (251293561)
- Deutsche Forschungsgemeinschaft (B09 INST 40/682‐1)
- Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg (MWK25‐0123‐139/1/11)
This publication has 50 references indexed in Scilit:
- Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise ReviewStem Cells Translational Medicine, 2019
- SIRT3/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stressCell Death & Differentiation, 2017
- Cysteine-linked dimerization of BST-2 confers anoikis resistance to breast cancer cells by negating proapoptotic activities to promote tumor cell survival and growthCell Death & Disease, 2017
- Transcription factor Elk-1 participates in the interleukin-1β-dependent regulation of expression of immediate early response gene 3 (IER3)Cytokine, 2014
- Induction of cyclooxygenase-2 expression by prostaglandin E2 stimulation of the prostanoid EP4 receptor via coupling to Gαi and transactivation of the epidermal growth factor receptor in HCA-7 human colon cancer cellsEuropean Journal of Pharmacology, 2013
- Osteoblast Isolation from Murine Calvaria and Long Bones2011
- Role of the immediate early response 3 (IER3) gene in cellular stress response, inflammation and tumorigenesisEuropean Journal of Cell Biology, 2011
- IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodelingCell Death & Differentiation, 2009
- Osteogenic differentiation of human mesenchymal stem cells on poly(ethylene glycol)‐variant biomaterialsJournal of Biomedical Materials Research Part A, 2008
- Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2Journal of Cellular Biochemistry, 2007